Dr. Truman obtained his Ph.D. in Biochemistry at University College London, UK, focusing on the interplay between molecular chaperones and MAP kinase pathways in yeast. He worked as a postdoctoral scholar at both Johns Hopkins University and Boston University under the advisement of Dr. David E. Levin, examining how MAP kinase specificity is achieved. He joined the University of Chicago as a Research Assistant Professor to gain expertise in phospho-proteomics and global interactomics under the mentorship of Dr. Stephen Kron. His studies on Hsp70 phosphorylation resulted in a 2012 publication in Cell. In 2015, he established his research lab at the University of North Carolina in Charlotte to study the role of chaperones in cancer and was promoted to Associate Professor with Tenure effective 1 July 2021. He is a Fellow of the Cell Stress Society (FSSI) and is a Senior Editor for Frontiers in Molecular Biosciences and Cell Stress and Chaperones. He has published over 40 papers in high-impact journals and is currently funded by multiple grants from the National Institutes of Health (NIH).
Dr. Truman obtained his Ph.D. in Biochemistry at University College London, UK, focusing on the interplay between molecular chaperones and MAP kinase pathways in yeast. He worked as a postdoctoral scholar at both Johns Hopkins University and Boston University under the advisement of Dr. David E. Levin, examining how MAP kinase specificity is achieved. He joined the University of Chicago as a Research Assistant Professor to gain expertise in phospho-proteomics and global interactomics under the mentorship of Dr. Stephen Kron. His studies on Hsp70 phosphorylation resulted in a 2012 publication in Cell. In 2015, he established his research lab at the University of North Carolina in Charlotte to study the role of chaperones in cancer and was promoted to Associate Professor with Tenure effective 1 July 2021. He is a Fellow of the Cell Stress Society (FSSI) and is a Senior Editor for Frontiers in Molecular Biosciences and Cell Stress and Chaperones. He has published over 40 papers in high-impact journals and is currently funded by multiple grants from the National Institutes of Health (NIH).